Kjell Mortier is a Fund Manager at Novalis Biotech, overseeing investments in early-stage life sciences companies. They have held various roles throughout their career, including Interim Manager at BioLizard and Principal Scientist Analytics at Eurofins Amatsigroup. Kjell is also a Board Member at RheaVita BVBA and RheumaFinder, actively contributing to the pharmaceutical and biotech sectors. They earned a PhD in Pharmaceutical Sciences from Universiteit Gent and are currently pursuing degrees in Accounting and Finance at EHSAL Management School and in Venture Capital and Private Equity at Vlerick Business School.
This person is not in the org chart
This person is not in any teams
This person is not in any offices